Literature DB >> 19091993

Generation of immune responses against hepatitis C virus by dendritic cells containing NS5 protein-coated microparticles.

Stephan Gehring1, Stephen H Gregory, Philip Wintermeyer, Costica Aloman, Jack R Wands.   

Abstract

Dendritic cells (DCs) internalize and process antigens as well as activate cellular immune responses. The aim of this study was to determine the capacity of DCs that contain antigen-coated magnetic beads to induce immunity against the nonstructural hepatitis C virus (HCV) antigen 5 (NS5). Splenocytes derived from Fms-like tyrosine kinase receptor 3 (Flt3) ligand-pretreated BALB/c mice were incubated with magnetic beads coated with HCV NS5, lipopolysaccharide (LPS), and/or anti-CD40; purified; and used for immunization. Cellular immunity was measured using cytotoxic T-lymphocyte (CTL) and T-cell proliferation assays, intracellular cytokine staining, and a syngeneic tumor challenge using NS5-expressing SP2/0 myeloma cells in vivo. Splenocytes isolated from animals vaccinated with DCs containing beads coated with NS5, LPS, and anti-CD40 secreted elevated levels of interleukin-2 (IL-2) and gamma interferon in the presence of NS5. The numbers of CD4(+), IL-2-producing cells were increased >5-fold in the group immunized with DCs containing beads coated with NS5, LPS, and anti-CD40, paralleled by an enhanced splenocyte proliferative response. Immunization promoted antigen-specific CTL activity threefold compared to the level for control mice and significantly reduced the growth of NS5-expressing tumor cells in vivo. Thus, strategies that employ NS5-coated beads induce cellular immune responses in mice, which correlate well with the natural immune responses that occur in individuals who resolve HCV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091993      PMCID: PMC2643538          DOI: 10.1128/CVI.00287-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  52 in total

1.  Intravenous injection of naked DNA encoding secreted flt3 ligand dramatically increases the number of dendritic cells and natural killer cells in vivo.

Authors:  Y He; A A Pimenov; J V Nayak; J Plowey; L D Falo; L Huang
Journal:  Hum Gene Ther       Date:  2000-03-01       Impact factor: 5.695

2.  Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells.

Authors:  J L Pooley; W R Heath; K Shortman
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

3.  Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity.

Authors:  Stephany M Standley; Ines Mende; Sarah L Goh; Young Jik Kwon; Tristan T Beaudette; Edgar G Engleman; Jean M J Fréchet
Journal:  Bioconjug Chem       Date:  2007 Jan-Feb       Impact factor: 4.774

4.  Different hepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope.

Authors:  C Brinster; S Muguet; Y C Lone; D Boucreux; N Renard; A Fournillier; F Lemonnier; G Inchauspé
Journal:  Hepatology       Date:  2001-12       Impact factor: 17.425

5.  Protection against persistence of hepatitis C.

Authors:  Shruti H Mehta; Andrea Cox; Donald R Hoover; Xiao-Hong Wang; Qing Mao; Stuart Ray; Steffanie A Strathdee; David Vlahov; David L Thomas
Journal:  Lancet       Date:  2002-04-27       Impact factor: 79.321

6.  Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection.

Authors:  S E Bassett; B Guerra; K Brasky; E Miskovsky; M Houghton; G R Klimpel; R E Lanford
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

7.  Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection.

Authors:  S Auffermann-Gretzinger; E B Keeffe; S Levy
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

Review 8.  Hepatitis C treatment update.

Authors:  Brian L Pearlman
Journal:  Am J Med       Date:  2004-09-01       Impact factor: 4.965

9.  Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C.

Authors:  David E Kaplan; Kazushi Sugimoto; Kimberly Newton; Mary E Valiga; Fusao Ikeda; Ayse Aytaman; Frederick A Nunes; Michael R Lucey; Barbara A Vance; Robert H Vonderheide; K Rajender Reddy; Jane A McKeating; Kyong-Mi Chang
Journal:  Gastroenterology       Date:  2006-11-29       Impact factor: 22.682

10.  Generation and characterization of an immunogenic dendritic cell population.

Authors:  Stephan Gehring; Stephen H Gregory; Philip Wintermeyer; Maryann San Martin; Costica Aloman; Jack R Wands
Journal:  J Immunol Methods       Date:  2008-01-14       Impact factor: 2.303

View more
  7 in total

1.  Chronic alcohol-induced liver disease inhibits dendritic cell function.

Authors:  Dechun Feng; Ahmet Eken; Vivian Ortiz; Jack R Wands
Journal:  Liver Int       Date:  2011-03-21       Impact factor: 5.828

Review 2.  Dendritic cell-based immunity and vaccination against hepatitis C virus infection.

Authors:  Yun Zhou; Ying Zhang; Zhiqiang Yao; Jonathan Patrick Moorman; Zhansheng Jia
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

3.  Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infection.

Authors:  Kazumasa Hiroishi; Junichi Eguchi; Shigeaki Ishii; Ayako Hiraide; Masashi Sakaki; Hiroyoshi Doi; Risa Omori; Michio Imawari
Journal:  J Biomed Biotechnol       Date:  2010-05-20

4.  Chronic ethanol diet increases regulatory T-cell activity and inhibits hepatitis C virus core-specific cellular immune responses in mice.

Authors:  Vivian Ortiz; Jack R Wands
Journal:  Hepatol Res       Date:  2013-07-04       Impact factor: 4.288

5.  A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients.

Authors:  Michael Duerr; Eva V Schrezenmeier; Lukas J Lehner; Léon Bergfeld; Petra Glander; Stephan R Marticorena Garcia; Christian E Althoff; Ingolf Sack; Susanne Brakemeier; Kai-Uwe Eckardt; Klemens Budde; Fabian Halleck
Journal:  BMC Nephrol       Date:  2019-02-04       Impact factor: 2.388

Review 6.  Co-Infection and Cancer: Host-Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses.

Authors:  Tania H Mulherkar; Daniel Joseph Gómez; Grace Sandel; Pooja Jain
Journal:  Viruses       Date:  2022-09-14       Impact factor: 5.818

7.  Generation of cellular immune responses to HCV NS5 protein through in vivo activation of dendritic cells.

Authors:  P Wintermeyer; S Gehring; A Eken; J R Wands
Journal:  J Viral Hepat       Date:  2010-10       Impact factor: 3.728

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.